Literature DB >> 23736142

Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen.

Ravinder Kaur1, Janet R Casey, Michael E Pichichero.   

Abstract

OBJECTIVE: We sought to determine whether recurrent acute otitis media (rAOM) occurring within 30 days of amoxicillin/clavulanate treatment was caused by bacterial relapse or new pathogens.
METHODS: Pneumococcal conjugate vaccinated children, age 6-36 months, enrolled in a prospective, longitudinal study experiencing rAOM<1 month after completing amoxicillin/clavulanate therapy were studied. AOM episodes occurred between June 2006 and November 2012. Multilocus sequence typing was used to genotype isolates.
RESULTS: Sixty-six children were in the study cohort; 63 otopathogens were recovered from middle ear fluid after tympanocentesis. Nontypeable Haemophilus influenzae (NTHi) accounted for 47% of initial AOMs versus 15% by Streptococcus pneumoniae (Spn), P<0.0001. NTHi accounted for 42% of rAOM versus 24% by Spn (P value=0.04). NTHi was the main otopathogen that caused true bacteriologic relapses (77%). β-lactamase-producing NTHi and penicillin nonsusceptible Spn were not more common in rAOM than initial AOM infections. Among 21 paired (initial and rAOM events) NTHi isolates genotyped, 13 (61.9%) were the same organism; 1 of 9 (11.1%) of paired Spn isolates was the same (P value=0.017). rAOM occurring within a week of stopping amoxicillin/clavulanate was a different pathogen in 21% of cases, 8-14 days later in 33%, 15-21 days in 41% and 22-30 days in 57% (P=0.04).
CONCLUSIONS: In amoxicillin/clavulanate-treated children, NTHi was the main otopathogen that caused true bacteriologic relapses. New pathogens causing rAOM versus persistence of the initial pathogen significantly increased week to week. Neither relapses nor new infections were caused more frequently by β-lactamase producing NTHi or penicillin nonsusceptible Spn.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23736142      PMCID: PMC3845822          DOI: 10.1097/INF.0b013e31829e3779

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  25 in total

1.  Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy.

Authors:  I Brook; P Yocum
Journal:  Pediatr Infect Dis J       Date:  1995-09       Impact factor: 2.129

2.  Assessment of otoscopists' accuracy regarding middle-ear effusion. Otoscopic validation.

Authors:  P H Kaleida; S E Stool
Journal:  Am J Dis Child       Date:  1992-04

3.  Cefprozil treatment of persistent and recurrent acute otitis media.

Authors:  M E Pichichero; S McLinn; G Aronovitz; R Fiddes; J Blumer; K Nelson; B Dashefsky
Journal:  Pediatr Infect Dis J       Date:  1997-05       Impact factor: 2.129

4.  A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media.

Authors:  M E Pichichero; S M Marsocci; M L Murphy; W Hoeger; A B Francis; J L Green
Journal:  Otolaryngol Head Neck Surg       Date:  2001-04       Impact factor: 3.497

5.  Persistent purulent otitis media.

Authors:  R H Schwartz; W J Rodriguez; W N Khan
Journal:  Clin Pediatr (Phila)       Date:  1981-07       Impact factor: 1.168

6.  Early recurrences of otitis media: reinfection or relapse?

Authors:  S A Carlin; C D Marchant; P A Shurin; C E Johnson; D Murdell-Panek; S J Barenkamp
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

7.  Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York.

Authors:  Janet R Casey; Ravinder Kaur; Victoria C Friedel; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

8.  Persistent acute otitis media: I. Causative pathogens.

Authors:  M E Pichichero; C L Pichichero
Journal:  Pediatr Infect Dis J       Date:  1995-03       Impact factor: 2.129

9.  Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media.

Authors:  C J Harrison; M I Marks; D F Welch
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

10.  Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain?

Authors:  S J Barenkamp; P A Shurin; C D Marchant; R B Karasic; S I Pelton; V M Howie; D M Granoff
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

View more
  7 in total

1.  Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.

Authors:  Ravinder Kaur; Matthew Morris; Michael E Pichichero
Journal:  Pediatrics       Date:  2017-08-07       Impact factor: 7.124

2.  Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection.

Authors:  Ravinder Kaur; Michael Pichichero
Journal:  Infect Immun       Date:  2022-04-18       Impact factor: 3.609

3.  Payment analysis of two diagnosis and management approaches of acute otitis media.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Clin Pediatr (Phila)       Date:  2014-05-09       Impact factor: 1.168

4.  Familial and microbiological contribution to the otitis-prone condition.

Authors:  Matthew C Morris; Anthony L Almudevar; Janet R Casey; Michael E Pichichero
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-10-13       Impact factor: 1.675

5.  Correlation of nasopharyngeal cultures prior to and at onset of acute otitis media with middle ear fluid cultures.

Authors:  Ravinder Kaur; Katerina Czup; Janet R Casey; Michael E Pichichero
Journal:  BMC Infect Dis       Date:  2014-12-05       Impact factor: 3.090

Review 6.  Recent Perspectives on Gene-Microbe Interactions Determining Predisposition to Otitis Media.

Authors:  Rahul Mittal; Sebastian V Sanchez-Luege; Shannon M Wagner; Denise Yan; Xue Zhong Liu
Journal:  Front Genet       Date:  2019-11-26       Impact factor: 4.599

7.  Defining the Binding Region in Factor H to Develop a Therapeutic Factor H-Fc Fusion Protein against Non-Typeable Haemophilus influenzae.

Authors:  Sandy M Wong; Jutamas Shaughnessy; Sanjay Ram; Brian J Akerley
Journal:  Front Cell Infect Microbiol       Date:  2016-04-13       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.